Protection of the kidney with sodium-glucose cotransporter 2 inhibitors: potential mechanisms raised by the...

Area of Science:

• Nephrology
• Cardiology
• Endocrinology

Background:

• Sodium-glucose cotransporter 2 (SGLT2) inhibitors have demonstrated significant cardio-renal protective effects.
• Key trials like CANVAS Program and EMPA-REG OUTCOME have spurred research into their mechanisms.
• Existing literature offers varied explanations for these protective effects.

Purpose of the Study:

• To provide a current overview of the renal protective effects of SGLT2 inhibitors in diabetic patients.
• To focus on the hemodynamic aspects and under-explored factors contributing to renal protection.
• To address unanswered questions regarding uric acid, lipids, erythropoiesis, oxidative stress, and the Na-H exchanger.

Main Methods:

• Literature review and synthesis of existing research.
• Focus on hemodynamic mechanisms of SGLT2 inhibition.
• Exploration of less-discussed factors influencing renal protection.

Main Results:

• SGLT2 inhibitors exhibit established hemodynamic benefits relevant to renal protection.
• Several other factors, including uric acid, lipids, erythropoiesis, oxidative stress, and Na-H exchange, are implicated but require further investigation.
• Discrepancies exist in the literature regarding the precise mechanisms.

Conclusions:

• SGLT2 inhibitors provide renal protection in diabetics through multiple pathways.
• Further research is needed to fully elucidate the roles of uric acid, lipids, oxidative stress, and other factors.
• A comprehensive understanding of these mechanisms is crucial for optimizing SGLT2 inhibitor therapy.